Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Feb 8;60(6):2796-2821.
doi: 10.1002/anie.202001520. Epub 2020 Nov 3.

Iridium-Catalysed C-H Borylation of Heteroarenes: Balancing Steric and Electronic Regiocontrol

Affiliations
Review

Iridium-Catalysed C-H Borylation of Heteroarenes: Balancing Steric and Electronic Regiocontrol

Jay S Wright et al. Angew Chem Int Ed Engl. .

Abstract

The iridium-catalysed borylation of aromatic C-H bonds has become the preferred method for the synthesis of aromatic organoboron compounds. The reaction is highly efficient, tolerant of a broad range of substituents and can be applied to both carbocyclic and heterocyclic substrates. The regioselectivity of C-H activation is dominated by steric considerations and there have been considerable efforts to develop more selective processes for less constrained substrates. However, most of these have focused on benzenoid-type substrates and in contrast, heteroarenes remain much desired but more challenging substrates with the position and/or nature of the heteroatom(s) significantly affecting reactivity and regioselectivity. This review will survey the borylation of heteroarenes, focusing on the influence of steric and electronic effects on regiochemical outcome and, by linking to current mechanistic understandings, will provide insights to what is currently possible and where further developments are required.

Keywords: borylation; catalysis; heteroarenes; iridium; regioselectivity.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Applications of organoboron compounds. MIDA=N‐methyliminodiacetic acid.
Figure 2
Figure 2
Selected classes of organoboron compounds.
Scheme 1
Scheme 1
Selected syntheses of aryl organoboron compounds; literature references given in square brackets. dppf=1,1′‐bis(diphenylphosphino)ferrocene, pin=pinacolyl, TMEDA=tetramethylethylenediamine.
Scheme 2
Scheme 2
Selected examples of electrophilic aromatic C−H borylation mediated by a) a borenium cation, b) frustrated Lewis pair catalysis, c) BI3.
Scheme 3
Scheme 3
Seminal reports of Ir‐catalysed C−H borylation. bpy=2,2′‐bipyridine, cod=1,5‐cyclooctadiene, dmpe=1,2‐bis(dimethylphosphino)ethane, Ind=indenyl.
Scheme 4
Scheme 4
Catalytic cycles of the Ir‐catalysed C−H borylation depicting catalyst regeneration using B2pin2 (blue) and HBpin (red). coe=cyclooctene.
Figure 3
Figure 3
Directed C−H borylation. a) Inner‐sphere, b) relay, and c) outer‐sphere mechanisms.
Scheme 5
Scheme 5
Ir‐catalyzed C−H borylation of arenes. mtbe=methyl tert‐butyl ether (IUPAC: 2‐methoxy‐2‐methylpropane).
Scheme 6
Scheme 6
Directed ortho borylation by a) inner‐sphere control using Silica‐SMAP, b) relay inner‐sphere borylation, c) outer‐sphere mediated coordination.
Scheme 7
Scheme 7
Reagent‐based regiocontrolled C−H borylation.
Scheme 8
Scheme 8
C−H borylation of 2‐phenylpyridine.
Scheme 9
Scheme 9
C‐2 selective C−H borylation of pyrrole, thiophene, and furan using a) excess heterocycle (* C‐3‐borylated furan also observed), b) stoichiometric heterocycle, c) room temperature.
Scheme 10
Scheme 10
C−H borylation of substituted pyrroles, thiophenes, and furans. dba=dibenzylideneacetone, Q‐phos=1′‐[bis(1,1‐dimethylethyl)phosphino]‐1,2,3,4,5‐pentaphenylferrocene.
Scheme 11
Scheme 11
C−H borylation of substituted thiophenes.
Scheme 12
Scheme 12
C−H borylation of N‐substituted pyrroles. S‐Phos=2‐dicyclohexylphosphino‐2′,6′‐dimethoxybiphenyl, TIPS=triisopropylsilyl.
Scheme 13
Scheme 13
Directed C−H borylation of five‐membered heterocycles. Cy=cyclohexyl.
Scheme 14
Scheme 14
Borylation of porphyrins and corroles.
Scheme 15
Scheme 15
C−H borylation of indoles. IMes=1,3‐bis(2,4,6‐trimethylphenyl)imidazolium.
Scheme 16
Scheme 16
C−H borylation of benzofused heterocycles.
Scheme 17
Scheme 17
ortho‐ and peri‐directed borylation of benzofused heterocycles.
Scheme 18
Scheme 18
Inner‐sphere directed borylation of indoles.
Scheme 19
Scheme 19
C−H borylation of indazoline derivatives. DMAc=dimethylacetamide.
Scheme 20
Scheme 20
Ir‐catalysed C−H borylation of pyridine.
Scheme 21
Scheme 21
C−H borylation of 2‐substituted pyridines. TMS=trimethylsilyl.
Scheme 22
Scheme 22
C−H borylation of substituted pyridines.
Scheme 23
Scheme 23
Borylation of 2,2‐bipyridines.
Scheme 24
Scheme 24
Outer‐sphere directed C−H borylation of pyridines.
Scheme 25
Scheme 25
Ligand‐mediated outer‐sphere directed C−H borylation of pyridines. OTf=triflate.
Scheme 26
Scheme 26
Inner‐sphere directed C−H borylation of 2‐substituted pyridines.
Scheme 27
Scheme 27
Ir‐catalysed C−H borylation of quinolines. NIS=N‐iodosuccinimide.
Scheme 28
Scheme 28
Directed borylation of quinolines.
Scheme 29
Scheme 29
Borylation of imidazole derivatives.
Scheme 30
Scheme 30
Borylation of pyrazole and its derivatives.
Scheme 31
Scheme 31
Borylation of oxazole derivatives.
Scheme 32
Scheme 32
C−H borylation of indazoles. Ms=methanesulfonyl.
Scheme 33
Scheme 33
Multidirectional functionalisations of 2H‐indazoles. SEM=2‐(trimethylsilyl)ethoxymethyl.
Scheme 34
Scheme 34
C−H borylation of benzoxazole, benzothiazole, and benzimidazole derivatives.
Scheme 35
Scheme 35
C−H borylation of diazines.
Scheme 36
Scheme 36
C−H borylation of boron‐containing heteroarenes.
Scheme 37
Scheme 37
C−H borylation of imidazo‐, pyrazolo‐ and tetrazolopyridine. Amphos=bis(di‐tert‐butyl(4‐dimethylaminophenyl)phosphine, DME=dimethyl ether, XPhos=2‐dicyclohexylphosphino‐2′,4′,6′‐triisopropylbiphenyl.
Scheme 38
Scheme 38
C−H borylation of fused heterocycles. μW=microwaves.

References

    1. Ward R. A., Kettle J. G., J. Med. Chem. 2011, 54, 4670–4677. - PubMed
    1. Vitaku E., Smith D. T., Njardarson J. T., J. Med. Chem. 2014, 57, 10257–10274. - PubMed
    1. Taylor A. R. D., Maccoss M., Lawson A. D. G., J. Med. Chem. 2014, 57, 5845–5859. - PubMed
    1. Pitt W., J. Med. Chem. 2009, 52, 2952–2963. - PubMed
    1. Newman D. J., Cragg G. M., J. Nat. Prod. 2016, 79, 629–661. - PubMed

Publication types